Total Valuation
JEIL PHARMA HOLDINGS INC. has a market cap or net worth of ₩106.38B. The enterprise value is ―.
Market Cap₩106.38B
Enterprise Value―
Share Statistics
JEIL PHARMA HOLDINGS INC. has 15,973,355 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding15,973,355
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
JEIL PHARMA HOLDINGS INC.’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 1.88%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)1.88%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee18.79B
Profits Per Employee418.15M
Employee Count35
Asset Turnover0.75
Inventory Turnover3.43
Valuation Ratios
The current PE Ratio of JEIL PHARMA HOLDINGS INC. is 7.9. JEIL PHARMA HOLDINGS INC.’s PEG ratio is -0.07.
PE Ratio7.9
PS Ratio0.20
PB Ratio0.40
Price to Fair Value0.40
Price to FCF-16.27
Price to Operating Cash Flow8.94
PEG Ratio-0.07
Income Statement
In the last 12 months, JEIL PHARMA HOLDINGS INC. had revenue of 657.61B and earned 14.64B in profits. Earnings per share was 953.37.
Revenue657.61B
Gross Profit226.27B
Operating Income15.07B
Pretax Income39.55B
Net Income14.64B
EBITDA30.02B
Earnings Per Share (EPS)953.37
Cash Flow
In the last 12 months, operating cash flow was 11.90B and capital expenditures -10.43B, giving a free cash flow of 1.46B billion.
Operating Cash Flow11.90B
Free Cash Flow1.46B
Free Cash Flow per Share91.58
Dividends & Yields
JEIL PHARMA HOLDINGS INC. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.17
52-Week Price Change-20.22%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)14.41K
Important Dates
JEIL PHARMA HOLDINGS INC. upcoming earnings date is Aug 7, 2026, TBA (Confirmed).
Last Earnings DateMay 15, 2026
Next Earnings DateAug 7, 2026
Ex-Dividend Date―
Financial Position
JEIL PHARMA HOLDINGS INC. as a current ratio of 1.16, with Debt / Equity ratio of 52.81%
Current Ratio1.16
Quick Ratio0.79
Debt to Market Cap1.30
Net Debt to EBITDA3.70
Interest Coverage Ratio2.01
Taxes
In the past 12 months, JEIL PHARMA HOLDINGS INC. has paid 4.72B in taxes.
Income Tax4.72B
Effective Tax Rate0.12
Enterprise Valuation
JEIL PHARMA HOLDINGS INC. EV to EBITDA ratio is 7.98, with an EV/FCF ratio of -30.36.
EV to Sales0.36
EV to EBITDA7.98
EV to Free Cash Flow-30.36
EV to Operating Cash Flow613.95
Balance Sheet
JEIL PHARMA HOLDINGS INC. has ₩83.36B in cash and marketable securities with ₩168.67B in debt, giving a net cash position of -₩85.31B billion.
Cash & Marketable Securities₩83.36B
Total Debt₩168.67B
Net Cash-₩85.31B
Net Cash Per Share-₩5.34K
Tangible Book Value Per Share₩28.34K
Margins
Gross margin is 39.56%, with operating margin of 2.29%, and net profit margin of 2.23%.
Gross Margin39.56%
Operating Margin2.29%
Pretax Margin6.01%
Net Profit Margin2.23%
EBITDA Margin4.57%
EBIT Margin2.29%
Analyst Forecast
The average price target for JEIL PHARMA HOLDINGS INC. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-21.06%
EPS Growth Forecast―